Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,016,449 papers from all fields of science
Search
Sign In
Create Free Account
ZIO 101
Known as:
ZIO-101
, ZIO101
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
darinaparsin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
S-Dimethylarsino-glutathione (darinaparsin®) targets histone H3.3, leading to TRAIL-induced apoptosis in leukemia cells.
Xiaohan Xu
,
Haibo Wang
,
+5 authors
Hongzhe Sun
Chemical Communications
2019
Corpus ID: 204739843
Histone H3.3 was identified as an arsenic-binding protein of S-dimethylarsino-glutathione (ZIO-101, darinaparsin®) in leukemia…
Expand
Review
2008
Review
2008
Chemical and clinical development of darinaparsin, a novel organic arsenic derivative.
A. Quintás-Cardama
,
S. Verstovsek
,
E. Freireich
,
H. Kantarjian
,
Yi Wen Chen
,
R. Zingaro
Anti-Cancer Agents in Medicinal Chemistry
2008
Corpus ID: 23957249
The inorganic arsenic derivative arsenic trioxide (ATO) has proven to be highly efficacious in patients with acute promyelocytic…
Expand
2007
2007
ZIO-101 (S-dimethylarsino-glutathione): Phase I/II trials in advanced/progressive multiple myeloma
J. Berenson
,
S. Jaganath
,
+6 authors
M. Hussein
2007
Corpus ID: 74074049
8109 Background: ZIO-101(S-dimethylarsino-glutathione), a novel organic arsenic, is active against multiple cancers including…
Expand
2007
2007
Organic arsenic in patients (pts) with advanced solid tumors: Phase-1 results of zio-101 (s-dimethylarsino-glutathione)
L. Camacho
,
D. Hong
,
+7 authors
R. Kurzrock
2007
Corpus ID: 58991184
3554 Background: ZIO-101(S-dimethylarsino-glutathione), a novel organic arsenic, is active against multiple cancers in vitro and…
Expand
2006
2006
Three-dimensional demonstration of the collateral circulation to the artery of Adamkiewicz with 16-row multislice computed tomography.
K. Yoshioka
,
H. Niinuma
,
Yoshinobu Ogino
,
K. Muranaka
,
K. Kawazoe
,
S. Ehara
Annals of Thoracic Surgery
2006
Corpus ID: 36505743
2006
2006
ZIO-101, a Novel Organic Arsenic, Inhibits Human Myeloma Cell Growth in a SCID-hu Model.
R. Campbell
,
Eric Sanchez
,
+11 authors
J. Berenson
2006
Corpus ID: 79338225
Inorganic arsenics like arsenic trioxide (ATO) are novel anti-cancer drugs active in acute promyelocytic leukemia (APL) and…
Expand
2006
2006
A phase 1 trial of a novel organic arsenic S-dimethylarsino-glutathione (ZIO-101) in hematological malignancies.
S. Kornblau
,
C. E. Jackson
,
+7 authors
S. Verstovsek
Journal of Clinical Oncology
2006
Corpus ID: 8914038
16503 Background: Inorganic Arsenicals (IA, e.g. AS2O3) kill many human leukemia cell lines and have efficacy in APL. Evaluation…
Expand
2005
2005
In Vitro Activity of a Novel Organic Arsenical (S-Dimethylarsino-Glutathione, ZIO-101) Against Multiple Myeloma.
L. Boise
,
A. Morales
,
D. Gutman
,
Kelvin P. Lee
2005
Corpus ID: 79009745
Arsenic Trioxide (ATO) has been shown to be highly active against acute promyelocytic leukemia (APL) and has activity in several…
Expand
2005
2005
Comparison of Uptake and Intracellular Induced Structural Changes of Arsenic Trioxide, an Inorganic Compound, and Organic Arsenic Derivative S-Dimethylarsino-Glutathione (SGLU; ZIO-101) in NB4 Acute…
T. Manshouri
,
S. V. Kala
,
+5 authors
S. Verstovsek
2005
Corpus ID: 79111937
Arsenic trioxide (As 2 O 3 ; ATO) inhibits proliferation and induces apoptosis of APL cells. However, little is known about the…
Expand
2005
2005
Mechanisms of increased reactive oxygen species (ROS) generation induced by organic arsenic derivative S-dimethylarsino-glutathione (SGLU ; ZIO-101).
Xiaodong Cheng
,
M. Taghi
,
+6 authors
S. Verstovsek
2005
Corpus ID: 89671199
ZIO-101 is organic arsenic with similar anti-leukemia activity to arsenic trioxide (ATO) but much less toxicity. Consequently…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE